Squarepoint
GSK icon

Squarepoint’s GSK GSK Stock Holding History

Squarepoint’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.4M Sell
79,700
-53,300
-40% -$2.89M 0.01% 1600
2025
Q4 		$6.52M Buy
133,000
+82,000
+161% +$3.82M 0.01% 1297
2025
Q3 		$2.2M Sell
51,000
-30,400
-37% -$1.19M ﹤0.01% 2015
2025
Q2 		$3.13M Buy
81,400
+64,900
+393% +$2.48M ﹤0.01% 1776
2025
Q1 		$639K Sell
16,500
-95,500
-85% -$3.5M ﹤0.01% 3066
2024
Q4 		$3.79M Buy
+112,000
New +$4.03M ﹤0.01% 1860
2024
Q3 		– Sell
-23,700
Closed -$912K – 4329
2024
Q2 		$912K Buy
+23,700
New +$997K ﹤0.01% 2624

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Squarepoint's GSK Position: Q1 2026 in Review

Squarepoint reduced its GSK (GSK) stake by 18% in Q1 2026, selling an estimated $764K and leaving 62,711 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

Squarepoint first reported a position in GSK in Q1 2019 and has held it in 24 quarters since. The position peaked at $9.28M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Squarepoint held 62,711 shares of GSK worth $3.46M as of Q1 2026.
  • Squarepoint sold 14,105 GSK shares in Q1 2026, an estimated $764K.
  • GSK made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1775 holding.
  • Squarepoint first reported a position in GSK in Q1 2019 and has held it in 24 quarters since.
  • Squarepoint's GSK position peaked at $9.28M in Q3 2022.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.